Affiliation:
1. U.S. Army Biological Laboratories, Fort Detrick, Frederick, Maryland
Abstract
Castleberry, Merida
W. (U.S. Army Biological Laboratories, Fort Detrick, Frederick, Md.),
John L. Converse, and Peter J. Soto, Jr.
Antibiotic control of tissue reactions in dogs vaccinated with viable cells of
Coccidioides immitis
. J. Bacteriol.
87:
1216–1220. 1964.—A total of 12 dogs (15 to 25 lb each), vaccinated with viable
Coccidioides immitis
(subcutaneous injection of 260 viable arthrospores in the medial surface of the hind leg), resisted a respiratory challenge (aerosol) with the same organism (13,000 viable arthrospores) administered (aerosol) 2 months after vaccination. Oral amphotericin B therapy (150 mg of Fungizone per day for 21 days) of 6 of the 12 dogs, initiated immediately after vaccination, eliminated the undesirable side reactions of the viable vaccine (ulcerated vaccination site and inguinal lymphadenopathy exhibited by the 6 untreated dogs) without affecting the immunogenicity of the vaccine. Clinical observation (blood-urea nitrogen levels) during and after therapy and histological examination approximately 3 months after respiratory challenge failed to disclose any evidence of nephrotoxicity or renal damage due to the oral antibiotic therapy (total doses of more than 3 g of amphotericin B).
Publisher
American Society for Microbiology
Subject
Molecular Biology,Microbiology
Reference14 articles.
1. CAMPBELL C. C. AND G. B. HILL. 1959. Beneficial therapeutic effects of solubilized amphotericin B following oral administration in experimental coccidioidomycosis histoplasmosis and cryptococcosis in mice. Trans. 4th Ann. Veterans Administration-Armed Forces Coccidioidomycosis Study Group Los Angeles Calif.
2. CASTLEBERRY M. W. J. L. CONVERSE J. T. SINSKI E. P. LOWE S. P. PAKES AND J. E. DEL FAVERO. 1963. Coccidioidomycosis studies: canine vaccination and therapy. Trans. 8th Ann. Veterans Administration-Armed Forces Coccidioidomycosis Study Group Los Angeles Calif.
3. CONVERSE J. L. M. W. CASTLEBERRY AND E. M. SNYDER. 1961. A viable prophylactic vaccine against coccidioidomycosis in monkeys. Trans. 6th Ann. Veterans Administration-Armed Forces Coccidioidomycosis Study Group Los Angeles Calif.
4. Pathogenesis of Coccidioides imimitis in monkeys;CONVERSE J. L.;J. Bacteriol.,1962
5. Immunization of mice against coccidioidomycosis;CONVERSE J. L.;J. Bacteriol.,1962
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Experimental Animal Models of Coccidioidomycosis;Annals of the New York Academy of Sciences;2007-03-01
2. Coccidioidomycosis: Host Response and Vaccine Development;Clinical Microbiology Reviews;2004-10
3. Vaccine Development for Coccidioidomycosis;Human Fungal Pathogens;2004
4. Coccidioidomycosis;Infectious Agents and Pathogenesis;1993
5. Development of vaccines for coccidioidomycosis;Mycopathologia et Mycologia Applicata;1970-09